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Measles virus (MV)-specific transcription in human brain cells is characterized by particularly low 
abundances of the distal mRNAs encoding the MV envelope proteins. Similar transcriptional restrictions of the 
closely related vesicular stomatitis virus have been observed in mouse fibroblasts constitutively expressing the 
interferon-inducible MxA protein (P. Staeheli and J. Pavlovic, J. Virol. 65:4498-4501, 1991). We found that MV 
infection of human brain cells is accompanied by rapid induction and high-level expression of endogenous MxA 
proteins. After stable transfection of MxA, human glioblastoma cells (U-87-MxA) released 50- to 100-fold less 
infectious virus and expression of viral proteinswas highly restricted. The overall MV-specific transcription 
Ievels were reduced by up to 90%, accompanied by low relative frequencies of the distal MV-specific mRNAs. 
These restrictions were linked to an inhibition of viral RNA synthesis and not to a decreased stability of the 
viral RNAs. Our results indicate that expression of MxA is associated with transcriptional attenuation of MV 
in brain cells, thus probably contributing to the establishment of persistent MV central nervous system 
infections. In addition, the mechanism of MxA-dependent resistance against MV infection, in contrast to that 
of vesicular Stomatitis virus, is cell type specific, because an inhibition of MV glycoprotein synthesis 
independent of transcriptional alterations was observed in MxA-transfected human monocytes (J.-J. Schnorr, 
S. Schneider-Schaulies, A. Simon-Jödicke, J. Pavlovic, M. A. Horisberger, and V. ter Meulen, J. Virol. 67: 
4760-4768, 1993). 
Measles virus (MV) gene expression in persistent infections 
of the human central nervaus system is characterized by the 
accumulation of viral ribonucleoprotein particles in neurons 
and glial cells and a strongly attenuated expression of the viral 
envelope proteins (3, 34). A hallmark of altered MV gene 
functions is the significant underrepresentation of the distal 
MV envelope gene-specific transcripts, which has been directly 
linked to the low expression of the corresponding proteins {5, 
6). On the basis of experiments with neural tissue culture cells, 
MV transcription has been suggested to be controlled by 
components intrinsic to the host cell or induced by differenti-
ation-dependent alterations of the intracellular cell metabo-
lism (30-33, 42). 
On the other band, MV infection of brain cells in vivo and in 
vitro is accompanied by the release of cytokines (13, 14, 29) 
that also may inftuence viral replication. This is based on the 
observation of type I interferon (IFN) in cerebraspinal fluid 
specimens of patients with persistent centrat nervaus system 
infections such as subacute sclerosing panencephalitis (SSPE) 
(13, 14, 19) andin MV infections ofbrain cells in tissue culture 
(16, 26, 29). In addition, IFN-escape variants have been linked 
to enhanced neurovirulence in an animal model (4). 
Among the variety of intracellular IFN-inducible proteins, 
the type I IFN-inducible Mx proteins have been characterized 
in the most detail and have been analyzed for their antiviral 
potential (36, 38). The nuclear mouse Mx1 protein was iden-
tified as an IFN-induced factor necessary and sufficient to 
confer a high degree of resistance exclusively to inftuenza A 
viruses to mammalian cells in tissue culture (17, 38, 43, 44). 
* Corresponding author. Mailing address: Institute for Virology and 
Immunobiology, Versbacher Str. 7, D-97078 Würzburg, Germany. 
Phone: 931-201-5954. Fax: 931-201-3934. 
6910 
Although the precise mechanisms interfering with primary 
transcription of inftuenza virus in Mx1-expressing cells have 
not been elucidated completely (17), the interference may be 
overcome by overexpression of the PB2 protein, which, to-
gether with its strict confinement to the nucleus, strongly 
suggests a direct interference with viral polymerase functions 
(12, 39). In contrast, the antiviral effects observed for the 
human cytoplasmic MxA protein are virus specific in restricting 
primary RNA synthesis of vesicular Stomatitisvirus (VSV) or 
inhibiting a step later than primary transcription for inftuenza 
virus in mouse 3T3 cells constitutively expressing MxA (23, 24, 
37). The MxA-dependent transcriptional inhibition of VSV 
was recently confirmed in stably MxA-transfected human 
monocytes. In the same study, a specific inhibition of viral 
glycoprotein synthesis independent of transcriptional restric-
tions was observed for MV in U-937 cells (35). It is suggestive 
that the multiple effects depend on host cell factors modifying 
the mode of action of MxA proteins (10, 27). 
Because high Ievels of Mx proteins have been found in 
MV-infected neural cells (16, 29), we investigated the potential 
role of this protein in attenuating MV gene functions in brain 
cells. After stable transfection of a human glioma cell line 
(U-87-MxA), production of infectious MV was reduced by up 
to 2 Iogs compared with that of MxA-nonexpressing controls, 
similar to the effect described before for U-937-MxA cells (35). 
However, in U-87-MxA cells, synthesis of MV-specific tran-
scripts was strongly attenuated, which was very similar to the 
restrictions described for VSV (37). Thus, these findings 
provide evidence that the antiviral activity of MxA protein may 
not only be virus and compartment specific but may also be 
host cell specific. In addition, the potential to attenuate MV 
gene functions in brain cells, tagether with the high Ievel of 
expression after primary MV infection of brain cell cultures, 
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renders the MxA protein a prime candidate for contributing to 
the establishment of persistent infections of the human centrat 
nervous system. 
MATERIALS AND METHODS 
Cell lines, viruses, IFN, and antibodies. Human glioblas-
toma D-54, U-251, U-138, D-32 (all kindly provided by D. 
Bigner [2, 40]), A-172, and U-87; neuroglioma H-4; neuroblas-
toma SK-N-MC, SK-N-BE, and IMR-32; and HEL (human 
embryonie lung fibroblasts [ all purchased from the American 
Type Culture Collection]) cells were grown in minimal essen-
tial medium containing 10% inactivated fetal calf serum. Vero 
cells (African green monkey kidney) were grown in minimal 
essential medium-5% fetal calf serum in the presence of 
penicillin-streptomycin. Stocks of the MV Edmonston strain 
and the New Jersey serotype of VSV were grown and passaged 
on Vero cells with titers of 5 x 106 to 1 X 107 PFU/ml (MV) 
and 1.5 X 109 PFU/ml (VSV). Recombinant IFN-ß was 
obtained from Merck and used at a concentration of 1,000 
U/ml for 24 h. Anti-IFN antibodies were used at final concen-
trations of 1,000 IFN neutralizing units (Boehringer, Mann-
heim, Oermany). The monoclonal MxA antibody was raised 
against pHisMxA protein purified from Escherichia coli (25). 
Establishment of stably transfected cell lines. U-87 cells 
lipofected with the expression plasmid APR-1-MxA (contain-
ing the entire coding sequence of the human MxA cDNA [1] 
under the control of the human ß-actin promoter [35]) or with 
vector DNA (8) lacking the MxA fragment were selected for 
their resistance to 0418 (500 IJ.g/ml). Transfectants were 
cloned twice by limiting dilution and analyzed for their MxA 
expression by immunofiuorescent staining and subsequent 
fiuorescence-activated cell sorter (FACScan) and Western 
immunoblot as described previously (35). Stahle cell clones 
were subsequently maintained in the presence of 500 ,...g of 
0418 per ml (Oibco BRL). Infection experiments with the 
transfectants were performed in standard medium lacking 
0418. 
RNA extraction and Northem (RNA) blot analysis. RNA 
extraction and Northern blot analyses were performed as 
described previously (30). pOemMV-N and pOemMV-H (5, 6) 
were used as linearized templates for in vitro transcription of 
[ 32P]CTP-labeled antisense probes. The rat pOAPDH (7) and 
pH0327/MxA (1) were Iabeted with [32P]dCTP by random 
priming by following the instructions of the manufacturer 
(Boehringer ). 
In vivo labeling of viral RNAs. Confiuent monolayers were 
infected with MV Edmonston strain (multiplicity of infection 
[MOl] of 1) for 18 h, starved for 1 hin phosphate-free medium 
(ICN Biochemicals) containing 50 ,...g of actinomycin D per ml, 
and subsequently labeled with 500 ,...ci of 32Pi per ml in the 
presence of 20 ,...g of actinomycin D per ml for the time 
intervals indicated. Under these conditions, no detectable 
incorporation of Iabel into cellular transcripts was apparent in 
uninfected cells (9, 20, 22, 41). After labeling, cells were 
extensively washed and chased in complete medium for the 
time intervals indicated or immediately harvested. Primary 
RNA synthesis was analyzed by direct labeling ( described 
above) for 6 h after MV infection with an MOl of 10 in the 
presence of 20 ,...g of cycloheximide per ml and 20 ,...g of 
actinomycin D per ml. Under these conditions, no incorpora-
tion of [35S]methionine was detected in trichloroacetic acid-
precipitable total cellular proteins (not shown). Total RNAs 
were prepared, separated on formaldehyde-containing agarose 
gels, and blotted onto a nitrocellulose filter. Quantification of 
the signals obtained was performed by scanning Iaser densi-
tometry with a Molecular Dynamics Phosphorlmager. 
RESULTS 
Expression and induction of MxA in cells of neural origin. 
In brain material isolated from patients with SSPE, expression 
of MxA-specific mRNA was associated with the presence of 
MV N-specific mRNA transcripts (Fig. 1a, lanes 2, 4, 6, 8, and 
9), whereas MV -negative brain RNA samples from these 
patients (Fig. 1a, lanes 3, 5, and 7) were essentially negative for 
MxA mRNA. As revealed by immunofiuorescence staining of 
SSPE brain sections, uninfected cells in the vicinity of infected 
ones expressed MxA, suggesting the induction of this protein 
by a soluble factor, most likely IFN (not shown). 
In MV -infected tissue cultures, the expression of the MV 
N-specific protein was preceeded by high Ievels of MxA 
proteins in some neural cell lines, as shown for the glioma cell 
line D-54 (Fig. lb and Table 1), but not in HEL cells (Fig. 1c) 
used as nonneural control cells. However, in both cell lines, 
comparable Ievels of MxA could be induced upon exogenaus 
treatment with recombinant IFN-ß (Fig. 1b and c, lanes 6 and 
5, respectively). Titrationexperiments revealed that induction 
of MxA in D-54 and U-251 cells required up to 50-fold less 
IFN-ß than was required for HEL cells (not shown). Induction 
of MxA by MV infection could be reduced by about 60% in the 
presence of anti-IFN-ß antibodies, but not with anti-IFN-a and 
anti-IFN--y antibodies, in all celllines tested (not shown). 
A comparative analysis of several cell lines of neural origin 
revealed that a generally low Ievel of MV -specific transcrip-
tional efficiency ( as determined by the steady-state Ievels of the 
N-specific mRNAs per infected cell) and the occurrence of 
highly polar expression gradients for the MV -specific mRNAs 
roughly correlated with the ability of the corresponding cell 
line to express high Ievels of MxA protein in response to MV 
infection (Table 1 ). This was most pronounced for the glioma 
celllines D-32 and D-54 and was slightly less pronounced for 
U-251 and H-4 (32). The neuronal cell lines did not express 
MxA after MV infection, but MxA expression could be in-
duced by exogenaus IFN-ß (Table 1 ). 
These results indicate that a rapid and high Ievel of expres-
sion of endogenaus MxA may occur in brain cells upon MV 
infection, which roughly correlates with the extent of transcrip-
tional restrictions observed in the persistently infected human 
brain. 
Downregulation of MV synthesis in stably MxA·transfected 
brain cells. To correlate restriction of MV gene expression in 
brain cells with the expression of MxA, U-87 cells were chosen 
for stable transfection of MxA because they did not express 
detectable amounts of endogenaus MxA after MV infection 
but could be induced to do so by exogenaus IFN treatment 
(Table 1). Compared with U-138, A-172, and the neuronal cell 
lines, which were also negative for MxA upon MV infection, 
U-87 cells are highly permissive for MV replication, as indi-
cated by the steady-state Ievels of the N-specific transcripts 
(Table 1 ). Thus, potential MxA-dependent restrictions of 
primary viral gene functions should be easily identified. 
After transfection, several independent G-418-resistant 
U-87 clones were tested for their ability to express the MxA 
protein by indirect immunoftuorescence staining and subse-
quent analysis by FACscan. In addition, Western blot analyses 
were performed to confirm the expression of the entire protein 
(not shown). Although almost 100% of the transfected cells 
stained positive for MxA, individual differences between clones 
that were high expressors (represented by U-87-H4 and U-87-
Dll) and those that were intermediate expressors (U-87-E4 
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FIG. 1. Expression of MxA proteins in MV-infected human neural 
cells. (a) Each 10 JJ.g of total RNA isolated from IFN-ß-treated U-251 
glioma cells (1,000 U/ml for 24 h) (lane 1) and different brain regions 
of three patients with SSPE (patient A, lanes 2 to 4; patient B, lanes 5 
and 6; patient C, lanes 7 to 9) was separated on formaldehyde-
containing agarose gels, blotted, and hybridized to Iabeted probes 
specific for MxA (upper panel), MV N mRNA (middle panel) and rat 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (bottom pan-
el). The positions of the corresponding mRNA transcripts are indi-
cated by arrowheads, and the bands migrating more highly, visible in 
the MV N-specific hybridization, represent bicistronic virus-specific 
transcripts. (band c) Western blot analyses of each 10-~g total protein 
extract of D-54 (b) and HEL (c) cells infected with MV (MOl of 0.1) 
for the time intervals indicated (b, lanes 1 to 5; c, lanes 1 to 4) or left 
uninfected but treated with exogenous IFN-ß (1,000 U/ml for 24 h) (b, 
lane 6; c, Iane 5). Blots were stained with monoclonal antibodies 
J. VIROL. 
TABLE 1. Expression of MxA proteinsinhuman brain cellsa 
Attenuation of MV MxA expressionb Cell type transcription° MV IFN-ß 
SSPE brain U+++ +c +d 
D-32 U+++ + + 
D-54 U+++ + + 
U-251 II++ + + 
U-138 II+ 
H-4 II++ + + 
U-87 Hf++ + 
A-172 1/++ 
SK-N-MC U++ + 
SK-N-BE II++ + 
IMR-32 II++ + 
a Transcriptional efficiency of MV was determined as copy numbers of the 
N-specific transcript per cell. MV transcription gradients reflecting the relative 
frequencies of the MV-specific distal mRNAs in relation to their individual N 
gene mRNAs (n = 100%) were determined by quantitative Northem blot 
analyses of RNA isolated after 40 h of MV infection (MOl of 0.5) as described 
previously (30). Data shown for the SSPE brains and the cell lines D-32, D-54, 
U-251, and U-138 have been published previously (32). Cell lines D-32, D-54, 
U-251, U-138, U-87, and A-172 are glioblastomas; H-4 is a neuroglioma; and 
SK-N-MC, SK-N-BE, and IMR-32 are cell lines of neuronal origin. Transcrip-
tional efficiency is indicated as high (H (similar to nonneural controls, ranging 
between 15,000 and 20,000 copies per cell]), low (L [ ranging from 2,000 to 6,000 
copies per cell]) and intermediate (1). The extent of attenuation of the 
MV -specific distal mRNAs was graded according to the following scale: + + +, 
strongly polar gradient, to +, flat, Vero cell-like gradient. 
b Expression of the IFN-inducible MxA protein was determined in each 10-~g 
total protein extract of each individual cellline after infection with MV (MOl of 
1) for 24, 48, and 72 h or, altematively, after 24 h of IFN-ß- treatment (1,000 
U/ml) by Western blot analysis. MxA expression in brain tissue was tested in 
three independerit cases of SSPE by indirect immunofluorescence staining of 
frozen tissue sections. 
c See Fig. 1a. 
d Suggested by the presence of IFN in cerebraspinal fluid (13, 14). 
and U-87-A8) of MxA protein could be observed. As negative 
controls, the parentalline (U-87) and two clones stably trans-
fected with the vector DNA (U-87-K4, U-87~K13) were used 
(Table 2 and Fig. 2). The antiviral activity of the transfected 
MxA prott~in in the high-level MxA-expressing clones (U-
87-H4 and U-87-Dll} was confirmed by its ability to interfere 
with VSV replication in a plaque reduction assay as described 
previously (24) (data not shown). 
After 18 h of infection with MV (MOl of 1), the appearance 
of the cytopathic effect in the individual culttires correlated 
inversely with the expression of MxA (Fig; 2). Widespread 
cytopathic effect characterized by the formation of giant cells 
was apparent in the non-MxA-expressing control cells (repre-
sentatively shown for U-87-K4 in Fig. 2a), while a progressively 
less-pronounced cytopathic effect was observed in U-87-AS 
and U-87-H4 cells (Fig. 2b and c). No cytopathic effect 
was apparent in U-87-011 cells, which were undistinguishable 
from uninfected U-87 cells (Fig. 2d). Thus, resistance of U-87 
cells to MV infection is conferred by transfection of MxA, 
similar to our previous observations with stably MxA-:trans-
fected human monocytes (U-937-MxA) (35). Comparable to 
the titers found for U-937-MxA cells, the titers of infectious 
virus released from U-87-MxA cells after the first replication 
cycle were reduced up to 100-fold, depending on the Ievel 
against the 60-kDa MV N protein and the 78-kDa MxA protein (the 
positions of the corresponding signals are indicated by arrows ). 
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T ABLE 2. MV yield in stably MxA-transfected human brain cells and nonexpressing controlst' 
MOl 
MV titer (MxA expression -, +, + + + )b in cell line 
U-87 (-) K4 (-) K13 (-) AS (+) E4 (+) H4 (+++) 011 (+++) 
10 7X1oJ 5 X 1oJ 4 X 1oJ 2X1Q2 4 X Hf 2 X 102 7 X 101 
1 6X1Q2 1 X 1oJ 5 X 102 1 X 1()2 4 X 101 1 X 101 <101 
0.1 3 X 1()2 2 X 102 1 X 102 1 X 101 <101 <<101 
" Supernalants were removed after 24 h of infection with the input MOls indicated and titrated on Vero cells. The titers indicated were determined in triple assays. 
b- to +++ indicates the Ievel of MxA expression in the individual cell clone as determined by indirect immunoftuorescence and FACscan. 
of MxA expression in the culture (Table 2). The yield of 
infectious viruswas reduced in U-87-H4 and U-87-Dll cells 
between 50- and 100-fold compared with that in the controls, 
whereas the effect was less pronounced in U-87-E4 and 
U-87-A8 cells. In addition, attenuation of MV replication was 
less pronounced in all celllines at high MOls, indicating that 
the resistance conferred by MxA can be overcome by high 
doses ofvirus. In contrast to our results with U-937-MxA cells, 
however, accumulation of the MV N and P proteins was 
reduced within the first replication cycle in MxA-expressing 
U-87-cells (U-87-H4 and U-87-Dll) compared with that in the 
MxA-nonexpressing controls (represented by U-87-K4) (Fig. 
3). After infection with an MOl of 10 (Fig. 3a, lanes 1, 3, and 
5), the steady-state Ievels of the MV N and (particularly visible 
in the figure) the MV P proteins were reduced, whereas MV 
N-specific signals were almost absent from U-87-MxA cells 
after infection with an MOl of 1 (Fig. 3a, lanes 4 and 6). 
Interestingly, the extent of restriction of MV proteins was 
directly correlated with the different amounts of MxA ex-
pressed in U-87-H4 and U-87-011 cells as determined by 
F ACscan (Fig. 3b ). 
Restrietion of MV-specific transcription in U-87-MxA cells. 
MV-specific RNA synthesis in U-87-H4, U-87-Dll, and, for 
control, U-87-K4 cells was analyzed 16 h after infection with an 
MOl of 1 by in vivo labeling with 32Pi for 6 hin the presence 
of actinomycin D (Fig. 4a). Synthesis of cellular RNAs was 
abolished ( see Materials and Methods ), and signals specific for 
the major MV -specific subgenomic mRNAs, except L, were 
detected in all three cell Iines. However, in U-87-H4 and 
U-87-Dll cells, MV N- and P-specific transcripts were present 
to only 10 and 13%, respectively (Fig. 4a, lanes 2 and 3) 
compared with those in U-87-K4 cells (Fig. 4a, lane 1). To 
investigate the MxA-dependent regulation of MV primary 
transcription, cells (U-87 K4, U-87-E4, U-87-H4, and U-87-
011) were directly labeled during the first 6 h after MV 
infection with an MOl of 10 in the presence of actinomycin D 
and cycloheximide (Fig. 4b). Under these conditions, the 
relative expression Ievels for the only detectable primary 
MV-specific N (and P) transcripts were 72% for U-87-E4 (Fig. 
4b, lane 3), 47% for U-87-H4 (Fig. 4b, lane 2), and 32% for 
U-87-Dll (Fig. 4b, lane 4) compared with those for the 
non-MxA-expressing U-87-K4 cells (Fig. 4b, lane 1). Synthesis 
FIG. 2. Morphology of MV-infected U-87-MxA cells. Transfeeted celllines (MxA expression graded by - to + + + +) were infected with MV 
(MOl of 1) for 18 h. The MV-specific cytopathic effect is evident by rounding of the cells and formation of large syncytia (a). (a) Oone U-87-K4 
(-). (b) Clone U-87-A8 (+). (c) Clone U-87-H4 (+++). (d) Oone U-87-Dll (++++).In panel a, significant amounts of cells were already 
detached. 
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FIG. 3. MV N-specific protein expression in U-87-MxA cells. (a) 
Each 10-~g total protein extract frorn U-87-K4 (lanes 1 and 2), 
U-87-H4 (lanes 3 and 4), and U-87-Dll (lanes 5 and 6) cells infected 
with MV at an MOl of 10 (lanes 1, 3, and 5) or 1 (lanes 2, 4, and 6) for 
18 h was analyzed by Western blotting with a polyclonal anti-MV 
serurn (the positions of the N and P proteins are indicated by arrows). 
(b) The expression of the MxA protein in U-87-K4-, U-87-H4, and 
U-87-Dll cells used for the infection experirnent in Fig. 3a was 
determined by indirect irnmunoftuorescence with a monoclonal anti-
MxA antibody as described previously (35). 
of MV -specific primary transcripts could not be detected with 
lower input MOls (not shown). 
Because RNase activities associated with subviral particles 
of VSV isolated from IFN-treated cells have been described 
(18), additional restrictions provided by an altered stability of 
MV-specific transcripts in U-87-K4, U-87-A8, and U-87-Dll 
cells were analyzed. After 16 h of infection, cells were pulse-
labeled for 2 h and subsequently chased for 3 and 6 h (Fig. 4c). 
As for the previous long-term labeling experiments (Fig. 4a), 
the generat transcriptional efficiency correlated inversely with 
the Ievel of MxA expression in the celllines (Fig. 4c, lanes 1, 4, 
and 7). In this particular experiment, overall virus-specific 
transcription, as determined by the frequencies of the N- and 
P-specific transcripts, was reduced by 30% for U-87-A8 and by 
65% for U-87-Dll compared with that for the control. How-
ever, no significant differences for the stability of the MV-
specific transcripts ( referring to the monocistronic as weil as 
the polycistronic RNAs) in the cell Iines analyzed could be 
a. 
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FIG. 4. MV-specific transcription in U-87-MxA cells. (a) MV-
specific RNA synthesis was determined by a 6-h labeling in the 
presence of 32P; and 20 ~g of actinomycin D per rnl after 18 h of 
infection with an MOl of 1 in U-87 transfectants expressing no (lane 1) 
or high Ievels (lanes 2 and 3) of MxA proteins. The positions of the 
mono- and polycistronic MV-specific transcripts are indicated by 
arrows. (b) Primary synthesis of MV-specific transcripts in U-87-K4 
(lane 1), U-87-H4 (lane 2), U-87-E4 (lane 3), and U-87-Dll (Iane 4) 
cells was determined by direct labeling within the first 6 h after 
infection in the presence of 32P; (500 ~Ci/mi), cyclohexirnide (20 
~g/ml), and actinornycin D (20 ~g/rnl). The positions of the N- and 
P-specific transcripts are indicated. (For comparison, the positive 
control of the long-term labeling experiment [Fig. 4a, lane 1] that was 
performed in parallel has been mounted (Fig. 4b, lane la).) Signals 
were quantified by phosphorimaging. Because they were extremely 
weak, the Iaser printer image is shown instead of an X-ray exposure. 
(c) U-87-transfectants expressing no (U-87-K4, lanes 1 to 3}, interme-
diate (U-87-A8, lanes 4 to 6), or high (U-87-Dll, lanes 7 to 9) Ievels 
of MxA proteins were pulse-labeled with 32P; after 18 h of infection 
(MOl of 1) for 2 hin the presence of 20 ~g of actinomycin D per ml 
and subsequently chased for the time intervals indicated. RNAs were 
isolated and separated by gel electrophoresis. The positions of the 
mono- and polycistronic transcripts are indicated by arrows. Signals 
were quantified by phosphorimaging. 
identified-(Table 3). (It should be noted that signalsnot visible 
in the figure [e.g., F/H in Fig. 4c, lanes 5 to 9] were detectable 
and quantifiable by phosphorimaging.) lnterestingly, in the 
exposure shown in Fig. 4c, signals specific for the distal 
mRNAs (F/H) can be seen in U-87-K4 cells 6 h after the chase 
(Fig. 4c, lane 3) but not in U-87-Dll cells after a 3-h chase 
(Fig. 4c, lane 8), although the N- and P-specific signals were 
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T ABLE 3. Stability of MV -specific monocistronic mRNAs 
in U-87-MxA cells 
MVmRNA" 
N/P 
M 
F/H 
Half-life (h) of MV-specific mRNA in celllineb 
U-87-K4c 
3 
3.5 
3.6 
U-87-H4 
2.5 
3 
3 
U-87-Dll 
3 
3 
3.2 
" N- and P-specific and F- and H-specific signals were comigrating and could 
not be quantified individually. 
b The half-lives of the MV-specific transcripts in U-87-MxA cells were 
determined after a pulse-labeling for 2 h and subsequent chasing for 3 and 6 h 
as shown in Fig. 4c. Signals for the discernible MV-specific RNAs were 
quantified by phosphorimaging. Note that bands not visible in Fig. 4c could be 
detected by this procedure. 
c U-87 cells expressed either no (U-87-K4 (see Fig. 4c, lanes 1 to 3]) or high 
(U-87-H4 and U-87-Dll [see Fig. 4c, lanes 4 to 6 and 7 to 9, respectively]) Ievels 
ofMxA. 
comparatively higher for the U-87-Dll cells (again, compare 
lanes 3 and 8 in Fig. 4c), thus indicating an underrepresenta-
tion of the distal mRNAs in this cell line. 
Decreased frequency of the distal mRNAs in MxA-express-
ing cells. Signals for the distal MV-specific mRNAs in U-87-
MxA cells were generally weak under in vivo labeling condi-
tions because of the attenuation of the overall MV -specific 
transcription (Fig. 4). Therefore, the steady-state Ievels of the 
N- and H-specific mRNAs in the U-87-H4 and U-87-K13 cell 
lines 24 h after infection with input MOls of 10 and 1, 
respectively, were comparatively analyzed (Fig. 5). The RNAs 
isolated from U-87-H4 cells were applied in 10-fold excess over 
U-87-K13 RNAs to roughly adjust the concentrations of the 
N-specific transcripts (Fig. 5a). In fact, in this particular 
experiment, the signal intensities for the N-specific transcript 
in U-87-H4 cells (Fig. 5a, lane 3) were 1.5-fold higher than 
those for U-87-K13 cells (Fig. 5a, lane 1) after infection with an 
MOl of 10 and 1.2-fold higher after infection with an MOl of 
1 (Fig. 5a, lanes 2 and 4, respectively) in U-87-H4 cells. 
Hybridization of the same RNAs with the H-specific probe 
a. b. 
2 3 4 1 2 3 4 
-bi 
-H 
FIG. 5. Relative frequencies of the MV-specific distal mRNAs in 
U-87-MxA cells. Each 2 ,.,.g of RNA isolated from U-87-K13 cells (a 
and b, lanes 1 and 2) and 20 ,.,.g of RNA from U-87-H4 cells (a and b, 
lanes 3 and 4) after infection with MOls of 10 (a and b, lanes 1 and 3) 
and 1 (a and b, lanes 2 and 4) were separated on formaldehyde-
containing agarose gels, blotted, and hybridized to riboprobes specific 
for the MV N-specific (a) and MV H-specific (b) positive-strand 
RNAs. Specific signals (indicated by arrows for the mono- and 
bicistronic [bi] transcripts) were quantified by phosphorimaging. 
The high-molecular-weight bands in panel b could not be reliably 
identified. 
revealed that, in U-87-K13 cells, the H-specific mRNA was 
expressed at relative frequencies of 22 and 15%, respectively 
(Fig. Sb, lanes 1 and 2), whereas in H4 cells the relative 
frequencies were only 5 and 0.2% of those of the correspond-
ing N-specific mRNAs (Fig. 5b, lanes 3 and 4). Again, restric-
tions are less pronounced upon high doses of infection (com-
pare Table 2 and Fig. 3 and 4 ). 
Together with the data obtained by in vivo labeling, these 
results indicate that the generat efficiency of MV-specific 
transcription and the relative frequencies of the distal MV-
specific mRNAs are attenuated in MxA-expressing U-87 cells. 
DISCUSSION 
Our data show that the cytoplasmic human IFN-inducible 
MxA protein is able to confer resistance to MV infection in 
brain cells. In these cells, MxA-dependent restrictions of MV 
gene expression are similar to those observed previously for 
VSV in affecting the synthesis ofvirus-specific RNAs (37). The 
attenuation, which is not primarily linked to destabilization of 
the MV transcripts, was observed for both total transcriptional 
efficiency and for the relative frequencies of the distal mRNAs. 
Because this particular transcriptional pattern is typically 
observed in human brain cells after primary MV infection (30, 
32) andin persistently infected human brain tissue (33), MxA 
may be considered an important intracellular factor for the 
establishment of MV persistence in the human centrat nervous 
system. 
Although MV nucleocapsids are ubiquitously present in 
SSPE brain tissue, glial cells and neurons are the main target 
cells for MV (34 ). In tissue culture, detectable amounts of 
MxA are expressed in neuroblastoma cells after Stimulation 
with exogenous IFN, but not after MV infection itself (Table 
1). Recent mRNA analyses confirmed that MV infection of 
these cells does not induce the synthesis of IFN-ß-specific 
mRNA (28). In contrast, glial cells respond to MV infection 
with a rapid induction of IFN-ß, as revealed by Northern blots, 
analyses of cell supernatants, and the inhibition of MxA 
induction by anti-IFN -ß antibodies ( reference 29 and this 
report). Thus, the expression of MxA in neurons in vivo is 
probably induced by exogenous IFN released from MV-in-
fected glial cells. 
In U-87-MxA cells, the extent of resistance to MV infection 
strictly correlates with the expression Ievel of the transfected 
MxA in the individual U-87-MxA clones, thus rendering an 
artificial inhibitory effect due to the integration site of the 
transfected DNA unlikely. The MxA-mediated inhibition of 
MV transcription, and subsequently virus release, was less 
pronounced than that of VSV (24). However, we could en-
hance this effect with exogenous IFN-ß (data not shown), 
indicating that MxA may be necessary, but not sufficient, to 
completely inhibit MV replication in IFN-treated cells. The 
role of other IFN-inducible proteins in regulating MV gene 
functions has not yet been analyzed. It is conceivable that the 
incomplete MxA-dependent inhibition of MV in brain cells 
may be further enhanced by additional differentiation-depen-
dent control mechanisms affecting viral transcription and/or 
translation (33, 42). 
In contrast to ourfindings in U-937 monocytes, expression of 
MxA affected the expression of intemal MV structural proteins 
N and P rather than that of the glycoproteins (Fig. 3a [35]). 
The expression of N protein, clearly coinciding with the 
expression of MxA in the individual cell lines, is undoubtedly 
strongly affected at an input MOl of 1 (Fig. 3a, lanes 2, 4, and 
6). At higher doses of virus (Fig. 3a, lanes 1, 3, and 5), the 
reduction of N protein expression seems to be less pro-
6916 SCHNEIDER-SCHAULIES ET AL. 
nounced, whereas it is clearly visible for the second abundant 
protein, the P protein. This finding may in part be explained by 
the subsequent RNA analyses (Fig. 4b [also described below]). 
On the other band, the steady-state Ievels of N protein 
detected 18 h postinfection, particularly with high Ievels of 
input MOls, may also reflect the presence of residual N protein 
derived from the infecting particles. Indeed, we could show 
that in some brain celllines, including U-87, the half-lives of N 
proteins range from 12 h to 16 h (29a). 
In U-87-MxA cells, the overall efficiency of MV-specific 
transcription proved to be highly reduced (Fig. 4a ). The effect 
on viral primary RNA synthesis, analyzed in the presence of 
cycloheximide, was apparently less pronounced ( araund 60% 
instead of 90% [Fig. 4a and b ]). Signals obtained for MV 
primary RNA synthesis are, however, in generat substantially 
weak because the primary transcription of MV is rather slow 
compared with that of VSV. Thus, MV primary RNA synthesis 
can only be detected with high doses of virus (high MOl of 10). 
Under these infection conditions, however, the MxA-depen-
dent downregulation of MV replication was less effective (Fig. 
3 and Table 2). In that context, however, it should be noted 
that, for VSV as well, the inhibition of primary RNA synthesis 
as determined in the presence of cycloheximide is less pro-
nounced than that determined in the absence of the drug (37). 
Transcriptional regulation of MV in U-87-MxA cells also 
affects the relative frequencies of the distal mRNAs, leading to 
highly polar expression gradients as observed for VSV in 
mause 3T3-MxA and human U-937-MxA cells (Fig. 4c and 5) 
(35, 37). Although, as is the case for VSV, the distal mRNAs 
are Ionger than the proximal mRNAs located at the 3' end of 
the genome, a selective instability could not be observed for 
these transcripts in U-87-MxA cells because the half-lives of 
the individual transcripts were comparable (Fig. 5 and Table 
3). Although we cannot formally rule out an enhanced RNase 
activity, it is not likely that this activity would be confined to the 
2-h labeling period used in the pulse-chase experiment and it 
would not affect the half-lives of the individual mRNAs during 
the chase period. In addition, no evidence for an enhanced 
instability of the distal mRNAs could be detected after MV 
infection of D-54 cells that spontaneously reveal strongly polar 
expression gradients for the MV -specific mRNAs in the pres-
ence of high amounts ofendogenaus MxA (not shown). 
Previous studies clearly indicated that the antiviral activities 
of Mx proteins are dependent on their intracellular localization 
and are specific for different viruses (23, 44). Our study 
provides direct evidence that resistance conferred by MxA for 
the same virus (MV) is host cell dependent in attenuating viral 
transcription in brain cells and synthesis of MV glycoproteins 
in monocytes without any impairment of viral transcription 
(35). In support of the cell type specificity of MxA to restriet 
MV gene expression, growth of MV was unaffected in MxA-
transfected Vero cells (15, 29a). 
The hypothesis that MxA-mediated mechanisms imposed on 
MV gene expression have to be rather different is also sup-
ported by their ability to distinguish between VSV and MV in 
U-937 cells and not in brain cells (35). Unfortunately, the 
comparative analysis could not be extended to the originally 
established 3T3-MxA cells (24), because these cells and the 
parental 3T3 cell line are not permissive for MV replication. 
The basis for the host cell-specific differences observed for 
MxA-dependent MV gene regulation in U-937 and U-87 cells 
is not understood, although they seem to be mutually exclusive. 
All of our attempts to find alterations of MV transcription in 
monocytes failed (35). In cantrast to the parental U-87 cells, 
MV transcription was already substantially low and the expres-
sion gradient for the MV -specific transcripts was highly polar 
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in the parental U-937 cell line, indicating that, in these cells, 
transcriptional attenuation of MV occurs independently of 
MxA expression. The primary site of interference with MV 
replication for MxA in U-87 brain cells is viral RNA synthesis, 
and, consequently, the steady-state Ievels of the viral distal 
mRNAs, including those specific for the glycoproteins, are 
extremely low. However, additional control mechanisms im-
posed on posttranscriptional Ievels cannot be ruled out. 
The mode of action of Mx proteins has not been elucidated 
yet. They have been designated as members of a new class of 
GTPases with antiviral activity (38). Tripartite GTP binding 
consensus elements have been identified at the N termini of 
the proteins (11), and more recently, their capacity to bind and 
to hydrolyze GTP has been confirmed (25). Moreover, by use 
of deletion mutants, evidence for a relationship between their 
antiviral activity and a functional GTP binding motif has been 
obtained (25, 43). However, because deletions or mutations 
within carboxy-terminal sequences of MxA proteins have been 
associated with their complete functionalloss, sites critical for 
the antiviral effect, probably directly interacting with viral 
constituents, have been suggested (43). The functional rele-
vance of this domain was further supported by a mutant with 
just one amino acid exchange at position 645 that completely 
lost its ability to interfer with VSV replication but still was able 
to inhibit influenza virus replication ( 43). 
Physical interactions of MxA with cellular cytoskeletal pro-
teins, such as actin and tubulin, were observed (10, 27). 
Although in vitro MV and VSV transcription and replication 
have been found to be positively regulated by cellular compo-
nents, including actin and tubulin (20, 21 ), the ubiquitous 
expression of these proteins renders a role in cell-type-specific 
regulation of MV transcription rather unlikely. Unfortunately, 
all attempts, including our own, to positively identify a direct 
interaction of MxA with viral structural proteins have failed 
(39). Thus, a functional interaction of MxA with viral or host 
cell constituents, probably related to the ability of MxA to bind 
and hydrolyze GTP (25), has to be anticipated. 
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